183 related articles for article (PubMed ID: 33407243)
1. Is the sharp increasing trend of multiple sclerosis incidence real in Iran?
Hosseinzadeh A; Sedighi B; Kermanchi J; Heidari M; Haghdoost AA
BMC Neurol; 2021 Jan; 21(1):7. PubMed ID: 33407243
[TBL] [Abstract][Full Text] [Related]
2. Incidence of multiple sclerosis in Iran: a nationwide, population-based study.
Hosseinzadeh A; Baneshi MR; Sedighi B; Kermanchi J; Haghdoost AA
Public Health; 2019 Oct; 175():138-144. PubMed ID: 31476710
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis incidence temporal trend in the Northeast of Iran: Using the Empirical Bayesian method.
Taghizadeh-Diva SE; Khosravi A; Zolfaghari S; Hosseinzadeh A
Mult Scler Relat Disord; 2023 Feb; 70():104469. PubMed ID: 36587485
[TBL] [Abstract][Full Text] [Related]
4. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?
Mohebi F; Eskandarieh S; Mansournia MA; Mohajer B; Sahraian MA
Arch Iran Med; 2019 Aug; 22(8):429-434. PubMed ID: 31679345
[TBL] [Abstract][Full Text] [Related]
5. Geographic variations of multiple sclerosis in Iran: A population based study.
Hosseinzadeh A; Baneshi MR; Sedighi B; Kermanchi J; Haghdoost AA
Mult Scler Relat Disord; 2019 Feb; 28():244-249. PubMed ID: 30634104
[TBL] [Abstract][Full Text] [Related]
6. Do socioeconomic factors affect the prevalence of multiple sclerosis in Iran?
Pakdel M; Karin Hedström A; Bidkhori M; Hadei M; Kazemi Moghaddam V; Sarmadi M; Zohdi S; Marufi N
Acta Neurol Scand; 2019 Nov; 140(5):328-335. PubMed ID: 31291697
[TBL] [Abstract][Full Text] [Related]
7. Joinpoint Regression Analysis of Trends in Multiple Sclerosis Incidence in Kuwait: 1980-2019.
Akhtar S; Al-Abkal J; Alroughani R
Neuroepidemiology; 2020; 54(6):472-481. PubMed ID: 33176327
[TBL] [Abstract][Full Text] [Related]
8. Estimated prevalence and incidence of multiple sclerosis in Iran.
Etemadifar M; Izadi S; Nikseresht A; Sharifian M; Sahraian MA; Nasr Z
Eur Neurol; 2014; 72(5-6):370-4. PubMed ID: 25341473
[TBL] [Abstract][Full Text] [Related]
9. Temporal Incidence and Prevalence Trends of Multiple Sclerosis in Markazi Province, Iran.
Faraji F; Ahmadi F; Mohaghegh P; Talaie A
Mult Scler Relat Disord; 2022 Apr; 60():103691. PubMed ID: 35217485
[TBL] [Abstract][Full Text] [Related]
10. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999-2015.
Eskandarieh S; Allahabadi NS; Sadeghi M; Sahraian MA
BMC Neurol; 2018 Feb; 18(1):15. PubMed ID: 29415659
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.
Salehi Z; Almasi-Hashiani A; Sahraian MA; Ashtari F; Baghbanian SM; Razazian N; Moghadasi AN; Bayati A; Azimi AR; Beladimoghadam N; Harirchian MH; Poursadeghfard M; Navardi S; Shirkoohi R; Heidari H; Ghaffari M; Eskandarieh S
BMC Neurol; 2022 Mar; 22(1):76. PubMed ID: 35248009
[TBL] [Abstract][Full Text] [Related]
12. Ongoing increase in incidence and prevalence of multiple sclerosis in south-eastern Iran: A three decade study.
Moghtaderi A; Shahidi-Pourakbari M; Izadi S; Khosravi A; Hashemzehi Z
Mult Scler Relat Disord; 2023 Mar; 71():104557. PubMed ID: 36857854
[TBL] [Abstract][Full Text] [Related]
13. Burden of multiple sclerosis in Iran from 1990 to 2017.
Fattahi N; Saeedi Moghaddam S; Mohebi F; Rezaei N; Masinaei M; Fateh SM; Soleymani Hassanlouei E; Manoochehri F; Fattahi E; Sahraian MA; Moradi-Lakeh M; Mokdad AH; Naghavi M; Farzadfar F
BMC Neurol; 2021 Oct; 21(1):400. PubMed ID: 34654397
[TBL] [Abstract][Full Text] [Related]
14. 18-year temporal trend of multiple sclerosis in southern Iran.
Mobasheri F; Fararouei M; Hasanzadeh J; Jaberi AR
Mult Scler Relat Disord; 2021 Jul; 52():103018. PubMed ID: 34023774
[TBL] [Abstract][Full Text] [Related]
15. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
16. Age-Period-Cohort Modeling of Multiple Sclerosis Incidence Rates in Kuwait: 1980-2014.
Akhtar S; Al-Abkal J; Al-Hashel JY; Alroughani R
Neuroepidemiology; 2017; 49(3-4):152-159. PubMed ID: 29161697
[TBL] [Abstract][Full Text] [Related]
17. Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.
Sarmadi M; Saravani H; Azizi O; Najafi F; Hadei M; Momeni J; Bazrafshan E
Neurol Sci; 2022 Jan; 43(1):583-591. PubMed ID: 33939041
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prevalence of multiple sclerosis in southeastern Iran.
Moghtaderi A; Rakhshanizadeh F; Shahraki-Ibrahimi S
Clin Neurol Neurosurg; 2013 Mar; 115(3):304-8. PubMed ID: 22717599
[TBL] [Abstract][Full Text] [Related]
19. Age and sex adjusted prevalence and annual incidence of multiple sclerosis in East-Azerbaijan, Iran.
Talebi M; Sadigh-Eteghad S; Sahraian MA; Fahidi A
Mult Scler Relat Disord; 2021 May; 50():102839. PubMed ID: 33592381
[TBL] [Abstract][Full Text] [Related]
20. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Maghzi AH
Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
